CRNX Stock Crinetics Pharmaceuticals Inc.
US
$44.00
—
Prices as of close 2026-10-27
Last in our picks 2026-10-20 — not in the current list; analysis below is from that screen
Late-stage endocrine pipeline catalysts offer significant biotechnology re-rating potential.
Future value: $65.00 (+47.70%) · 6-12 months
Signal breakdown
- ▸Pipeline catalysts and biotech risk appetite support speculative accumulation.
Is CRNX a buy right now?
Our screen: WATCH (score 0) — Late-stage endocrine pipeline catalysts offer significant biotechnology re-rating potential.
Computed from end-of-day data; not personal advice.
Related Health Care picks
BMRNBioMarin PharmaceuticaIONSIonis Pharmaceuticals,BSXBoston Scientific CorpSYKStryker CorporationUNHUnitedHealth Group IncHUMHumana Inc.BMYBristol-Myers Squibb CHNGEHinge Health, Inc.
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.